Location: Centre for Molecular Medicine and Therapeutics
950 West 28th Avenue Vancouver, BC V5Z 4H4 Canada
Category: Research Associate, Goldowitz Laboratory
Duration: One-year term
Tenure: Full-time; term appointment, Grant funded
The Centre for Molecular Medicine and Therapeutics at the University of British Columbia seeks applications for a Research Associate in Developmental Neurobiology.
The successful candidate will lead research projects that use functional genomics and high-throughput research strategies to identify and validate gene candidates and gene networks critical for neuronal specification and differentiation in the developing mammalian brain.
The Candidate is expected to manage the efforts of lab members in conjunction with the Principle Investigator across three major research areas. Firstly, the candidate will lead the efforts of a collaborative team in the generation and analysis of high throughput gene expression data with a focus on temporal expression pattern analysis. Secondly, the candidate will use experimental embryological techniques to identify the cellular/molecular events disrupted in mutant lines of mice in collaboration with other international research teams. Third, the candidate will facilitate the development and coordination of a national Developmental Neurosciences research training opportunities in conjunction with a Networks of Centres of Excellence of Canada, for which the Principle Investigator is the Scientific Director.
The Lab research aims to understand the genetic controls of neuronal development and facilitate training of developmental neuroscientists in translational and clinical sciences.
The successful candidate will hold a Ph.D. in Developmental Neurobiology, Cell Biology, or related field and a minimum of 8 years related research and management experience.
- The candidate is expected to supervise and mentor postdoctoral fellows, graduate students and technicians in the laboratory, requiring experience and demonstration of strong project management skills and providing direct assistance to trainees;
- Must have up-to-date knowledge of scientific tools and technologies of genomics and bioinformatics and the expertise in the areas of molecular genetics, primary neuronal cell culture analysis, and histological analyses to be able to teach trainees/visiting scientists to utilize these techniques in their research programs;
- Must be experienced in the development of functional genomics/expression assays, RNA/DNA techniques, in vitro and in vivo systems gene delivery and analysis;
- Must have practical experience and a keen working knowledge of laboratory animal assisted reproduction and mouse embryology necessary for carrying out studies of embryo manipulation in both in utero and in vitro systems;
- Must have experience and documented portfolio in developing training/course work for developmental neurosciences, and be able to coordinate distance learning for a national audience (i.e. hosting and running Webinar/collaborative group discussions)
- Should have a strong track record in scientific publications and have demonstrated grant writing skills with a proven record of an ability to attract funding;
- The candidate should be highly collaborative, self-motivated, team-oriented, and have excellent communication skills.
Please email your cover letter and CV to Dawn Ng at firstname.lastname@example.org by the closing date March 6, 2018 at 4:30 pm PST. No phone calls, please.
Equity and diversity are essential to academic excellence. An open and diverse community fosters the inclusion of voices that have been underrepresented or discouraged. We encourage applications from members of groups that have been marginalized on any grounds enumerated under the B.C. Human Rights Code, including sex, sexual orientation, gender identity or expression, racialization, disability, political belief, religion, marital or family status, age, and/or status as a First Nation, Metis, Inuit, or Indigenous person.
All qualified candidates are encouraged to apply; however Canadians and permanent residents of Canada will be given priority.